National Lymphoma Workshop: April 1, 2023 – Virtual

Lymphoma Workshops

The National Lymphoma Workshop will be a virtual program to deliver live patient education programming during the COVID-19 pandemic. This program will still provide access to local lymphoma experts, and you can join online. Please continue to check this page for updates. For updates on digital programs, please ensure you are subscribed to receive emails from the Lymphoma Research Foundation (LRF).

VIRTUAL – National Lymphoma Workshop: Understanding Lymphoma Basics and Current Treatment Options

DATE: Saturday, April 1, 2023
TIME:  10:00 AM ET – 3:30 PM ET
VIRTUAL PROGRAM – This is a virtual event, only accessible online.  Access instructions will be provided before event date.

About The Workshop

The Lymphoma Research Foundation’s Lymphoma Workshop provides the latest information about lymphoma, current treatment options and support issues to members of the lymphoma community across the United States. The National Lymphoma Workshop is the premier patient education and networking forum in the country.

Program Chairs

Nancy Bartlett, MD
Siteman Cancer Center
Washington University in St. Louis

Ryan Lynch, MD
Fred Hutch Cancer Center
University of Washington

Reasons To Attend

  • Learn about your specific type of lymphoma, treatment options, clinical trials and novel concepts during the comprehensive disease-specific breakout sessions.
  • Hear a variety of presentations and have your specific questions answered from our expert speaking faculty comprised of lymphoma specialists and patient support experts.

10:00 AM    Explore vFairs Space and Exhibit Hall

10:30 AM    Overview of Lymphoma – Neha Mehta Shah, MD, University of Washington in St. Louis

11:15 AM    Update on COVID-19 – Jeffrey Henderson, MD, PhD, University of Washington in St. Louis

12:00 PM    Networking Lounge and Exhibit Hall

12:15 PM    Breakout Sessions: Disease-Specific

  • Aggressive B-cell Non-Hodgkin Lymphomas: Newly Diagnosed – David Bond, MD, Ohio State University
  • Aggressive B-cell Non-Hodgkin Lymphomas: Relapsed/Refractory – Allison Rosenthal, DO, Mayo Clinic
  • Aggressive T-Cell Lymphomas – Bradley Haverkos, MD, University of Colorado
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Newly Diagnosed – Brad Kahl, MD, Washington University in St. Louis
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Relapsed/Refractory – Jacob Soumerai, MD, Massachusetts General Hospital
  • Cutaneous T-Cell Lymphomas – Michi Shinohara, MD, University of Washington
  • Follicular Lymphoma (FL) and Marginal Zone Lymphoma (MZL): Newly Diagnosed – Lorenzo Falchi, MD, Memorial Sloan Kettering Cancer Center
  • Follicular Lymphoma (FL) and Marginal Zone Lymphoma (MZL): Relapsed/Refractory – Nancy Bartlett, MD, Washington University in St. Louis
  • Hodgkin Lymphoma (HL) – Ryan Lynch, MD, Washington University
  • Mantle Cell Lymphoma (MCL): Newly Diagnosed – Peter Martin, MD, Weill Cornell/New York-Presbyterian
  • Mantle Cell Lymphoma (MCL): Relapsed/Refractory – Patrick Reagan, MD, University of Rochester
  • Waldenström Macroglobulinemia (WM) – Jonas Paludo, MD, Mayo Clinic

1:15 PM    Networking Lounge and Exhibit Hall

1:30 PM    Lymphoma Survivorship – Gita Thanarajasingam, MD, Mayo Clinic

2:30 PM    Immunotherapy and CAR T Cell Therapy – Loretta Nastoupil, MD, MD Anderson Cancer Center

3:30 PM   Workshop Concludes

To Register

VIRTUAL PROGRAM – This is a virtual event, only accessible online.  Access instructions will be provided after registration. This program will be accessible for up to a month following the event so please register even if you cannot attend the day of the live event.

For additional information, please contact a member of our Lymphoma Helpline staff at or (800) 500-9976.

This program is for patients and survivors, caregivers and program supporters. If you are a pharmaceutical industry professional that is interested in attending but your company is not listed as a sponsor, please email to learn more about sponsorship.

DisclaimerThe Lymphoma Research Foundation (LRF) is a national nonprofit organization based in the United States with educational programs and resources are intended for a US-based audience. These program and resources address available lymphoma treatments in the United States. and information on drug approvals by the US Food and Drug Administration.
For individuals outside of the US, LRF recommends the Lymphoma Coalition at The Lymphoma Coalition is a global network of worldwide nonprofit/NGO lymphoma patient organizations with information appropriate for non US-based audiences.

Program Partners

Program Supporters

This activity is supported by educational grants from:

National Presenting Supporter

National Gold Supporters

National Silver Supporter